Xinping Zhou

543 total citations
43 papers, 290 citations indexed

About

Xinping Zhou is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Xinping Zhou has authored 43 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 16 papers in Oncology and 15 papers in Genetics. Recurrent topics in Xinping Zhou's work include Acute Myeloid Leukemia Research (27 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Vascular Tumors and Angiosarcomas (5 papers). Xinping Zhou is often cited by papers focused on Acute Myeloid Leukemia Research (27 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Vascular Tumors and Angiosarcomas (5 papers). Xinping Zhou collaborates with scholars based in China, United States and Hong Kong. Xinping Zhou's co-authors include Hongyan Tong, Guobin Wang, Weifang Zhang, Yanling Ren, Jie Jin, Liya Ma, Chen Mei, Li Ye, Yingwan Luo and Weilai Xu and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Xinping Zhou

41 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinping Zhou China 8 152 96 92 57 29 43 290
Giulia Ceglie Italy 11 63 0.4× 115 1.2× 64 0.7× 17 0.3× 24 0.8× 22 261
Kathryn McElhinney United States 10 180 1.2× 137 1.4× 57 0.6× 45 0.8× 13 0.4× 26 298
W. Jeffrey Baker United States 8 84 0.6× 109 1.1× 64 0.7× 74 1.3× 16 0.6× 12 319
Hidetaka Niizuma Japan 12 52 0.3× 25 0.3× 136 1.5× 68 1.2× 34 1.2× 34 368
Imo J. Akpan United States 8 255 1.7× 236 2.5× 168 1.8× 17 0.3× 29 1.0× 21 475
Florence Pasquier France 11 169 1.1× 135 1.4× 112 1.2× 81 1.4× 15 0.5× 23 339
Francesca La Carpia United States 8 62 0.4× 48 0.5× 124 1.3× 14 0.2× 7 0.2× 15 281
Jens Chemnitz Germany 9 222 1.5× 60 0.6× 54 0.6× 162 2.8× 36 1.2× 20 527
C Sartiaux France 7 112 0.7× 68 0.7× 173 1.9× 45 0.8× 13 0.4× 8 505
Begoña Hurtado Spain 10 127 0.8× 35 0.4× 89 1.0× 18 0.3× 21 0.7× 19 404

Countries citing papers authored by Xinping Zhou

Since Specialization
Citations

This map shows the geographic impact of Xinping Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinping Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinping Zhou more than expected).

Fields of papers citing papers by Xinping Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinping Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinping Zhou. The network helps show where Xinping Zhou may publish in the future.

Co-authorship network of co-authors of Xinping Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xinping Zhou. A scholar is included among the top collaborators of Xinping Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinping Zhou. Xinping Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Geng, Cuizhi, Yueping Liu, Jianjun Han, et al.. (2024). A phase II trial comparing dalpiciclib in combination with letrozole versus standard chemotherapy as neoadjuvant therapy in patients with high-risk HR- positive HER-2 negative breast cancer: DARLING-02.. Journal of Clinical Oncology. 42(16_suppl). TPS626–TPS626. 1 indexed citations
3.
Wang, Chuanyu, Xiaojing Fan, Feiliang Wang, et al.. (2024). Clinical value of oral contrast-enhanced ultrasonography in diagnosis of gastric tumors. World Journal of Gastrointestinal Oncology. 16(1). 110–117. 1 indexed citations
4.
You, Liangshun, Yi Liu, Wenyuan Mai, et al.. (2024). Venetoclax plus cytarabine and azacitidine in relapsed/refractory AML: An open-label, single-arm, phase 2 study. European Journal of Cancer. 202. 113979–113979. 3 indexed citations
5.
Luo, Yingwan, Xiaomin Feng, Wei Lang, et al.. (2024). Ectopic expression of the transcription factor ONECUT3 drives a complex karyotype in myelodysplastic syndromes. Journal of Clinical Investigation. 134(8). 1 indexed citations
6.
7.
Ye, Li, Liya Ma, Yanling Ren, et al.. (2022). Predictive values of mutational variant allele frequency in overall survival and leukemic progression of myelodysplastic syndromes. Journal of Cancer Research and Clinical Oncology. 148(4). 845–856. 6 indexed citations
8.
9.
Ren, Yanling, Wei Lang, Chen Mei, et al.. (2022). Co‐mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome. Hematological Oncology. 41(1). 159–166. 7 indexed citations
10.
Zhang, Yi, Hanjin Yang, Xinping Zhou, et al.. (2020). Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study. Journal of Cancer Research and Clinical Oncology. 146(2). 357–365. 7 indexed citations
11.
12.
Luo, Yingwan, Lu Wang, Liya Ma, et al.. (2019). Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes. Cancer Science. 111(2). 580–591. 29 indexed citations
13.
Ye, Li, Yanling Ren, Xinping Zhou, et al.. (2019). Decitabine improves overall survival in myelodysplastic syndromes-RAEB patients aged ≥60 years and has lower toxicities: Comparison with low-dose chemotherapy. Blood Cells Molecules and Diseases. 77. 88–94. 4 indexed citations
14.
Wang, Ying, Xingxing Xu, Xinping Zhou, et al.. (2018). NMDA receptors inhibit axonal outgrowth by inactivating Akt and activating GSK-3β via calcineurin in cultured immature hippocampal neurons. Experimental Cell Research. 371(2). 389–398. 13 indexed citations
15.
Lin, Peipei, Yingwan Luo, Dominic Maggio, et al.. (2018). Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes. Journal of Cancer Research and Clinical Oncology. 144(6). 1037–1047. 17 indexed citations
16.
Zhou, Xinping, Juying Wei, Yinjun Lou, et al.. (2017). Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases. Frontiers of Medicine. 11(2). 287–292. 7 indexed citations
17.
Ma, Liya, et al.. (2016). Successful treatment of Candida tropicalis osteomyelitis with Micafungin in a leukemia patient. IDCases. 6. 109–111. 5 indexed citations
18.
Wang, Wei, Zhimei Chen, Mengxia Yu, et al.. (2015). [Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome].. PubMed. 36(10). 818–23. 1 indexed citations
19.
Wang, Guobin, et al.. (2013). The AKT/mTOR pathway mediates neuronal protective effects of erythropoietin in sepsis. Molecular and Cellular Biochemistry. 385(1-2). 125–132. 47 indexed citations
20.
Zhou, Xinping, Sy Ha, Gcf Chan, et al.. (2001). Successful mismatched sibling cord blood transplant in Hb Bart's disease. Bone Marrow Transplantation. 28(1). 105–107. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giulia Ceglie Breakdown of academic impact, for papers by Kathryn McElhinney Breakdown of academic impact, for papers by W. Jeffrey Baker Breakdown of academic impact, for papers by Hidetaka Niizuma Breakdown of academic impact, for papers by Imo J. Akpan Breakdown of academic impact, for papers by Florence Pasquier Breakdown of academic impact, for papers by Francesca La Carpia Breakdown of academic impact, for papers by Jens Chemnitz Breakdown of academic impact, for papers by C Sartiaux Breakdown of academic impact, for papers by Begoña Hurtado
Rankless by CCL
2026